Metrics to compare | ACOUS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACOUSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.7x | −12.8x | −0.4x | |
PEG Ratio | −0.15 | −0.29 | 0.00 | |
Price/Book | 5.9x | 5.7x | 2.6x | |
Price / LTM Sales | 8.0x | 17.4x | 3.0x | |
Upside (Analyst Target) | 188.0% | 149.5% | 51.9% | |
Fair Value Upside | Unlock | −11.5% | 9.4% | Unlock |
AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, a module that enables in-line analysis of blood plasma from whole blood samples; Acoustic Separation Module, a microfluidic solution that provides continuous separation, washing or up-concentration of cells; Acoustic Trapping Module, a microfluidic cell sorters or quality control systems for bioreactors and cell therapy production; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has a collaboration agreement with Moeller Medical to exhibit a prototype system for analyzing separation of cells from body fluids. AcouSort AB (publ) was incorporated in 2010 and is based in Lund, Sweden.